159 related articles for article (PubMed ID: 36660014)
1. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
Drugs Context; 2023; 12():. PubMed ID: 36660014
[TBL] [Abstract][Full Text] [Related]
2. An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
Shenoy M; Dhoot D; Mahajan H; Barkate H
Clin Cosmet Investig Dermatol; 2021; 14():1367-1376. PubMed ID: 34611418
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
Dermatology; 2024 May; ():1-13. PubMed ID: 38697027
[TBL] [Abstract][Full Text] [Related]
5. The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study.
Jain GK; Chitnis KR; Singhal P; Mahadkar N; Dhoot D; Barkate H
Cureus; 2023 Apr; 15(4):e37462. PubMed ID: 37187635
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
[TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
[TBL] [Abstract][Full Text] [Related]
8. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
[TBL] [Abstract][Full Text] [Related]
9. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
[TBL] [Abstract][Full Text] [Related]
10. Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
Sardana K; Mathachan SR
Indian Dermatol Online J; 2021; 12(1):1-5. PubMed ID: 33768016
[TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
Bhalavi H; Shaw D; Mehta H; Narang T; Sachdeva N; Shafiq N; Rudramurthy SM; Dogra S
Mycoses; 2023 Apr; 66(4):281-288. PubMed ID: 36457207
[TBL] [Abstract][Full Text] [Related]
12. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
[TBL] [Abstract][Full Text] [Related]
13. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions.
Rauseo AM; Mazi P; Lewis P; Burnett B; Mudge S; Spec A
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0013421. PubMed ID: 34031053
[TBL] [Abstract][Full Text] [Related]
15. Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.
Mino Y; Naito T; Watanabe T; Yamada T; Yagi T; Yamada H; Kawakami J
Clin Chim Acta; 2013 Jan; 415():128-32. PubMed ID: 23089073
[TBL] [Abstract][Full Text] [Related]
16. Assessment of antifungal efficacy of itraconazole loaded aspasomal cream: comparative clinical study.
Lamie C; Elmowafy E; Ragaie MH; Attia DA; Mortada ND
Drug Deliv; 2022 Dec; 29(1):1345-1357. PubMed ID: 35506466
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Adding Low-Dose Isotretinoin to Itraconazole in the Treatment of Chronic Recurrent Dermatophytosis among Sample of Iraqi Patients: An Open-Labelled Therapeutic Clinical Comparative Study.
Alhamdi DK; Alhamdi KI
Indian J Dermatol; 2022; 67(5):624. PubMed ID: 36865852
[TBL] [Abstract][Full Text] [Related]
18. Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.
Khurana A; Agarwal A; Agrawal D; Panesar S; Ghadlinge M; Sardana K; Sethia K; Malhotra S; Chauhan A; Mehta N
JAMA Dermatol; 2022 Sep; 158(11):1269-78. PubMed ID: 36103158
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
Sharma P; Bhalla M; Thami GP; Chander J
J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
[No Abstract] [Full Text] [Related]
20. Single dose and multiple dose studies of itraconazole nanoparticles.
Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
